HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease.

Abstract
Chronic obstructive pulmonary disease (COPD) is a life-threatening inflammatory respiratory disorder, often induced by cigarette smoke (CS) exposure. The development of effective therapies is impaired by a lack of understanding of the underlining mechanisms. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine with inflammatory and apoptotic properties. We interrogated a mouse model of CS-induced experimental COPD and human tissues to identify a novel role for TRAIL in COPD pathogenesis. CS exposure of wild-type mice increased TRAIL and its receptor messenger RNA (mRNA) expression and protein levels, as well as the number of TRAIL(+)CD11b(+) monocytes in the lung. TRAIL and its receptor mRNA were also increased in human COPD. CS-exposed TRAIL-deficient mice had decreased pulmonary inflammation, pro-inflammatory mediators, emphysema-like alveolar enlargement, and improved lung function. TRAIL-deficient mice also developed spontaneous small airway changes with increased epithelial cell thickness and collagen deposition, independent of CS exposure. Importantly, therapeutic neutralization of TRAIL, after the establishment of early-stage experimental COPD, reduced pulmonary inflammation, emphysema-like alveolar enlargement, and small airway changes. These data provide further evidence for TRAIL being a pivotal inflammatory factor in respiratory diseases, and the first preclinical evidence to suggest that therapeutic agents that target TRAIL may be effective in COPD therapy.
AuthorsT J Haw, M R Starkey, P M Nair, S Pavlidis, G Liu, D H Nguyen, A C Hsu, I Hanish, R Y Kim, A M Collison, M D Inman, P A Wark, P S Foster, D A Knight, J Mattes, H Yagita, I M Adcock, J C Horvat, P M Hansbro
JournalMucosal immunology (Mucosal Immunol) Vol. 9 Issue 4 Pg. 859-72 (07 2016) ISSN: 1935-3456 [Electronic] United States
PMID26555706 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Inflammation Mediators
  • RNA, Messenger
  • TNF-Related Apoptosis-Inducing Ligand
  • Tnfsf10 protein, mouse
Topics
  • Animals
  • Apoptosis
  • Disease Models, Animal
  • Female
  • Humans
  • Inflammation (immunology)
  • Inflammation Mediators (metabolism)
  • Lung (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Monocytes (immunology)
  • Pulmonary Disease, Chronic Obstructive (immunology)
  • RNA, Messenger (genetics)
  • Respiratory Mucosa (physiology)
  • Smoking (adverse effects)
  • TNF-Related Apoptosis-Inducing Ligand (genetics, metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: